[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100577032":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":7,"locations":8,"responsibleParty":47,"collaborators":50,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":7,"eligibilityCriteria":58,"healthyVolunteers":54,"sex":59,"minAge":60,"maxAge":7,"enrollmentInfo":61,"targetDuration":7,"studyType":64,"phases":7,"briefSummary":65,"conditions":66,"keywords":68,"overallStatus":11,"whyStopped":7,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Vilnius University","OTHER",null,[9,31],{"facility":10,"status":11,"city":12,"state":7,"zip":7,"country":13,"countryCode":14,"cosmosGeoPoint":15,"geoPoint":20,"contacts":21},"Vilnius University Hospital Santaros Klinikos","RECRUITING","Vilnius","Lithuania","LT",{"type":16,"coordinates":17},"Point",[18,19],25.2798,54.68916,{"lat":19,"lon":18},[22,27,29],{"name":23,"role":24,"phone":25,"phoneExt":7,"email":26},"Tomas Jovaisa, Prof","CONTACT","+37062697567","tomas.jovaisa@santa.lt",{"name":23,"role":28,"phone":7,"phoneExt":7,"email":7},"PRINCIPAL_INVESTIGATOR",{"name":30,"role":28,"phone":7,"phoneExt":7,"email":7},"Lina Puodziukaite",{"facility":32,"status":11,"city":33,"state":7,"zip":7,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":40,"contacts":41},"University Clinical Centre of the Medical University of Warsaw","Warsaw","Poland","PL",{"type":16,"coordinates":37},[38,39],21.01178,52.22977,{"lat":39,"lon":38},[42,46],{"name":43,"role":24,"phone":44,"phoneExt":7,"email":45},"Mateusz Zawadka, Dr","+48505018394","mateusz.zawadka@wum.edu.pl",{"name":43,"role":28,"phone":7,"phoneExt":7,"email":7},{"type":28,"investigatorFullName":48,"investigatorTitle":49,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Tomas Jovaisa","Prof",[51],{"name":10,"class":6},"100577032","diagnosis-treatment-and-outcome-assessment-of-septic-cardiomyopathy-using-an-integrated-mathematical-model-100577032",false,"NCT06793020","Diagnosis, Treatment, and Outcome Assessment of Septic Cardiomyopathy Using an Integrated Mathematical Model","Use of an Integrated Mathematical Model for the Diagnosis, Treatment and Outcome Assessment of Septic Cardiomyopathy","Inclusion Criteria:\n\n* Age 18 years or older;\n* Sepsis according to SEPSIS-3 criteria:\n* Suspected\u002Fconfirmed infection and\n* SOFA (Sequential Organ Failure Assessment) score ≥ 2 or qSOFA score ≥ 2;\n* Septic shock according to SEPSIS-3 criteria:\n* Sepsis is diagnosed and\n* Vasopressor infusion is used to maintain a mean arterial pressure (MAP) ≥ 65 mmHg and\n* Lactate \\> 2 mmol\u002Fl;\n* Cardiovascular support requirement for norepinephrine \\> 0.1 mcg\u002Fkg\u002Fmin infusion;\n* Signed informed consent form (ICF);\n\nExclusion Criteria:\n\n* Individuals under 18 years of age;\n* Has uncompensated cardiovascular disease:\n* Cardiogenic shock;\n* Congenital heart disease;\n* Heart failure NYHA functional class IV;\n* Refusal to participate in the study.","ALL","18 Years",{"count":62,"type":63},100,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to evaluate whether a new integrated mathematical model can improve the accuracy of diagnosing septic cardiomyopathy and predicting clinical outcomes in adult patients with suspected septic cardiomyopathy. The study aims to determine whether the integrated mathematical model enhances diagnostic accuracy and improves the prediction of clinical outcomes in these patients.",[67],"Septic Cardiomyopathy",[69,70,71],"Septic cardiomyopathy","Sepsis","Septic shock","2025-01-24",{"date":74,"type":75},"2025-01-27","ACTUAL",{"date":77,"type":75},"2024-03-17",{"date":79,"type":63},"2028-03",{"name":5,"class":6},2]